Lident

Epinephrine and Lidocaine Hydrochloride, the active ingredients in Lident, are a vasoconstrictor and local anesthetic presented as a solution for infiltration and perineural use. It provides rapid onset analgesia and reduces bleeding during minor surgical and dental procedures.

GNH USA supplies Lident as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Lident combines epinephrine and lidocaine to provide local anesthesia and hemostasis for procedures involving infiltration or nerve block.

- Dental procedures: delivers rapid local anesthesia while minimizing intra‑oral bleeding. - Minor skin surgery: facilitates analgesia and reduces operative bleeding. - Peripheral nerve block: extends the duration of anesthesia for limb surgeries.

Lident may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Injection site pain: transient discomfort at the site of administration. - Tachycardia: mild increase in heart rate. - Hypertension: temporary elevation of blood pressure. - Dizziness or light‑headedness. - Nausea or mild vomiting. - Local irritation or erythema.

Serious or Rare Side Effects: - Cardiac arrhythmias: potentially life‑threatening rhythm disturbances. - Severe hypertension or hypertensive crisis. - Allergic reactions: urticaria, bronchospasm, or anaphylaxis. - Seizures: due to systemic lidocaine toxicity. - Methemoglobinemia: rare discoloration of blood. - Cardiac arrest: extremely rare but critical emergency.

Before using Lident, consider the following safety measures.

- Cardiovascular assessment: avoid in patients with uncontrolled hypertension or severe cardiac disease. - Allergy screening: do not use if there is a known hypersensitivity to lidocaine, epinephrine, or any formulation components. - Dose limitation: adhere to recommended maximum doses to prevent systemic toxicity. - Concomitant medications: exercise caution when patients are on beta‑blockers, MAO inhibitors, or tricyclic antidepressants. - Pregnancy and lactation: safety not established; use only if benefits outweigh risks. - Store at room temperature: keep in original container, protect from moisture and light.

Lident can interact with several drug classes; some require avoidance while others need close monitoring.

Major Interactions (Avoid): - Beta‑blockers: may potentiate hypertension and bradycardia. - MAO inhibitors: increase risk of hypertensive crisis. - Tricyclic antidepressants: raise the likelihood of cardiac arrhythmias. - Other local anesthetics: cumulative systemic toxicity. - Sympathomimetic agents: amplify vasoconstrictive effects.

Moderate Interactions (Monitor Closely): - Non‑selective beta‑blockers: monitor heart rate and blood pressure. - Calcium channel blockers: watch for additive cardiovascular effects. - Diuretics: may alter plasma concentrations of lidocaine. - Antihypertensive agents: adjust dosing if significant blood pressure changes occur. - Other vasoconstrictors: assess for excessive vasoconstriction.